EUVIMEDEUVIMED entdecken
Crossref

Clinical characteristics and serum CA19 ‐9 combined with HE4 are valuable in diagnosing endometriosis‐associated ovarian cancer

Ting Xu, Lin Zhang, Yi Jiang, Yicong Wan, Shulin Zhou, Guodong Sun, Wenjun Cheng, Lin Yuan iD

International Journal of Gynecology & Obstetrics · 2023

DOI: 10.1002/ijgo.14695 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Gynecology & Obstetrics, 2023. Verfasst von Ting Xu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gynecology, The First Affiliated Hospital with Nanjing Medical University, Nanjing, China. Hauptthemen laut MEDLINE: Endometriosis, Ovarian Neoplasms. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 21 Literaturangaben. Gefördert von: Innovative Team of Jiangsu Province, Jiangsu Province Policy Guidance Program (International Science and Technology Cooperation/Hong Kong, Macao and Taiwan Science and Technology Cooperation), National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Endometriosis‐associated ovarian cancer (EAOC) is difficult to diagnose because of its low incidence, uncertain risk factors, and the absence of effective markers. This study aimed to investigate the clinical characteristics of EAOC and identify useful serological markers.

Methods

We retrospectively studied the clinical characteristics of patients with EAOC and ovarian endometriosis, obtained between January 1, 2011 and October 31, 2021. Univariate and multivariate logistic regression analyses were used to explore the relationship between clinical characteristics and EAOC. Receiver operating characteristic curves were applied to access the diagnostic value of serological markers in EAOC.

Results

In total, the clinical characteristics of 220 patients were obtained; 44 with EAOC and 176 with ovarian endometriosis. EAOC patients were older (46.20 vs. 36.26 years, P < 0.001) and had larger tumors (9.10 vs. 6.73 cm, P = 0.003) together with higher CA19‐9 (21.44 vs. 4.72 U/mL, P < 0.001) and HE4 levels (62.35 vs. 44.19 pmol/L, P < 0.001) when compared with ovarian endometriosis patients. Multivariate analysis showed that HE4 greater than 59.7 pmol/L, CA19‐9 greater than 8.5 U/mL, age 42 years or older, and tumor length 9.2 cm or longer were independent risk factors for EAOC. Significantly, CA19‐9 combined with HE4 had high sensitivity (72.73%) and specificity (78.41%) in diagnosing EAOC.

Conclusion

Age over 42 years, large ovarian tumor, serum CA19‐9 and HE4 are valuable in the diagnosis of EAOC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

EndometriosisOvarian NeoplasmsHumansFemaleAdultCA-19-9 AntigenRetrospective StudiesRisk FactorsCA-125 AntigenBiomarkers, Tumor

Stichwörter der Autor:innen

CA19-9HE4endometriosisendometriosis-associated ovarian cancer

Substanzen

CA-19-9 AntigenCA-125 AntigenBiomarkers, Tumor

Autor:innen und Institutionen

  • Department of Gynecology, The First Affiliated Hospital with Nanjing Medical University, Nanjing, China.

ORCID-Profile: Lin Yuan

Förderung

  • Innovative Team of Jiangsu Province
  • Jiangsu Province Policy Guidance Program (International Science and Technology Cooperation/Hong Kong, Macao and Taiwan Science and Technology Cooperation)
  • National Natural Science Foundation of China
  • Natural Science Research Program of Higher Education Institutions in Jiangsu Province
  • Scientific Research Project of Jiangsu Province Maternal and Child Health Association
  • Traditional Chinese Medicine Science and Technology Development Project in Jiangsu Province
  • Youth Scientist Fund of Jiangsu Basic Research Program
  • 333 High-level Talents Training Project in Jiangsu Province

Zitieren

APA

Xu, T., Zhang, L., Jiang, Y., Wan, Y., Zhou, S., Sun, G., Cheng, W., & Yuan, L. (2023). Clinical characteristics and serum CA19 ‐9 combined with HE4 are valuable in diagnosing endometriosis‐associated ovarian cancer. International Journal of Gynecology & Obstetrics. https://doi.org/10.1002/ijgo.14695

Vancouver

Xu T, Zhang L, Jiang Y, Wan Y, Zhou S, Sun G, et al. Clinical characteristics and serum CA19 ‐9 combined with HE4 are valuable in diagnosing endometriosis‐associated ovarian cancer. International Journal of Gynecology & Obstetrics. 2023. doi:10.1002/ijgo.14695

BibTeX
@article{Xu2023,
  author = {Xu, Ting and Zhang, Lin and Jiang, Yi and Wan, Yicong and Zhou, Shulin and Sun, Guodong and Cheng, Wenjun and Yuan, Lin},
  title = {Clinical characteristics and serum CA19 ‐9 combined with HE4 are valuable in diagnosing endometriosis‐associated ovarian cancer},
  journal = {International Journal of Gynecology & Obstetrics},
  year = {2023},
  doi = {10.1002/ijgo.14695}
}
Kostenlos starten →